NeuX has developed Interactive Neuromuscular Stimulation technology, a non-pharmaceutical, non-invasive and non-addictive means for treating chronic pain and injuries
Tampa, Fla.– NeuX Technologies, Inc. has joined the Tampa Bay Technology Incubator, part of USF CONNECT, at the University of South Florida.
NeuX Technologies is a medical technology, health and wellness company focused on developing solutions for the diagnosis, treatment and prevention of chronic pain and musculoskeletal injuries and conditions.
President and CEO Scott Minniear discovered USF’s incubation program at the Synapse Innovation Summit, which took place in Tampa Bay in late March and quickly identified it as a good fit.
“The Synapse Innovation Summit allows all players and personas of the start-up community to make meaningful connections," said Marc Blumenthal, co-founder of Synapse, a non-profit aimed at effectively facilitating and exposing Florida’s entrepreneurial ecosystem. “Helping entrepreneurs find the right resources means high-tech companies stay and grow in Florida. This partnership is one of many terrific examples of Synapse’s mission to connect the innovation ecosystem.”
NeuX has developed Interactive Neuromuscular Stimulation (INS) technology, a non-pharmaceutical, non-invasive and non-addictive means for treating chronic pain and injuries.
“Pain affects more people in the U.S. than diabetes, heart disease and cancer combined,” said Minniear. “INS can successfully locate and treat the root cause of pain, which can be distant from where the pain is felt.”
Though NeuX’s primary focus is chronic pain, INS technology can be utilized to treat musculoskeletal injuries and muscle conditioning to improve human performance. “Fifty-four percent of all Americans suffer from musculoskeletal conditions,” Minniear said. “This can result from repetitive motion, overuse, sports injuries, aging, disease and even poor posture.”
NeuX has patent-pending technology and expects to roll-out its first device later this year.
“We are very excited to welcome NeuX Technologies into the TBTI program,” said Valerie Landrio McDevitt, associate vice president for technology transfer and business partnerships. “Their goal to help people of all ages live a more active lifestyle, free of pain and injury through continued clinical studies and biomedical engineering research is an easy mission to get behind.”
To learn more about NeuX Technologies, Inc. visit:www.neuxtec.com
To learn more about Synapse and the 2019 Synapse Innovation Summit (January 23-24) visit:www.synapsefl.com
NeuX Technologies, Inc.
Tampa, Florida based NeuX Technologies is a medical technology, health and wellness company developing proprietary products and solutions for the diagnosis, treatment and prevention of chronic pain, musculoskeletal injuries and conditions based on its Interactive Neuromuscular Stimulation (INS) platform. Our patent pending technology will be a disruptive force in the marketplace and NeuX’s vision is to have their life changing technology become ubiquitous and available to everyone who is not living their lives to the fullest because of chronic pain, musculoskeletal injuries and conditions. For media inquiries, contact Scott Minniear at firstname.lastname@example.org, or by phone at 561-510-1882.
About the Tampa Bay Technology Incubator
The University of South Florida's (USF) Tampa Bay Technology Incubator (TBTI) is one vehicle through which USF CONNECT grows successful companies. USF CONNECT is a business and economic development initiative of USF that provides support for companies including technology and life science start-ups by facilitating access to top-tier research, programming, faculty, students, supporting organizations and funding sources.
About the University of South Florida
The University of South Florida, established in 1956 and located in Tampa, is a high-impact global research university dedicated to student success. The USF System includes three separately accredited institutions: USF, USF St. Petersburg and USF Sarasota-Manatee. Serving more than 50,000 students, the USF System has an annual budget of $1.8 billion and an annual economic impact of $4.4 billion. USF ranks in the top 30 nationally for research expenditures among public universities, according to the National Science Foundation. In 2018, the Florida Board of Governors designated USF as a Preeminent State Research University, placing USF in the most elite category among the state’s 12 public universities. USF is a member of the American Athletic Conference.